Randomised Sham-Controlled Trial
Cross-source consensus on Randomised Sham-Controlled Trial from 1 sources and 5 claims.
1 sources · 5 claims
Background
Other
Other
Highlighted claims
- The study is a single-centre, prospective, double-blind, sham-controlled, parallel-arm randomized trial with 1:1 block randomization. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
- The trial is registered at ClinicalTrials.gov as NCT06781593, registered on 29 April 2025. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
- The trial plans to include 130 patients, with 65 assigned to each arm. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
- Recruitment began in January 2025 and was ongoing when the manuscript was submitted. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial
- Investigators are blinded to active or sham BLT assignment, and centralized randomization is computed by REDCap. — Adjunctive bright light therapy to enhance continuous positive airway pressure adherence in patients with comorbid major depressive disorder and obstructive sleep apnoea syndrome: study protocol for a randomised sham-controlled trial